Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | ADK | P55263 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.31 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.31 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15140518 | 0.77 | ALDH1A1 (0.48) | ALDH1A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL207 | 0.77 | — | — | |
| SCHEMBL4964412 | 0.77 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL28418820 | 0.73 | — | — | |
| SCHEMBL28215470 | 0.71 | — | — | |
| SCHEMBL1032912 | 0.71 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL27125044 | 0.71 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL9737657 | 0.71 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL7049007 | 0.71 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2NISCHMTORADK | |
| SCHEMBL140714 | 0.71 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2NISCHMTORADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399695-B2 | Organometallic precursor compounds | PRAXAIR TECHNOLOGY, INC. (US) | 2013-03-19 | — | — | US | claimed |
| US-20110293852-A1 | ORGANOMETALLIC PRECURSOR COMPOUNDS | PRAXAIR TECHNOLOGY, INC. | 2011-12-01 | — | — | US | claimed |
| US-7332618-B2 | Organometallic precursor compounds | PRAXAIR TECHNOLOGY, INC. (US) | 2008-02-19 | — | — | US | claimed |
| EP-1805195-A2 | ORGANOMETALLIC PRECURSOR COMPOUNDS | PRAXAIR TECHNOLOGY, INC. (US) | 2007-07-11 | — | — | EP | claimed |
| WO-2006036538-A2 | ORGANOMETALLIC PRECURSOR COMPOUNDS | PRAXAIR TECHNOLOGY, INC. (US) | 2006-04-06 | — | — | WO | claimed |
| US-20060068102-A1 | Organometallic precursor compounds | PRAXAIR TECHNOLOGY, INC. | 2006-03-30 | — | — | US | claimed |
| US-8399695-B2 | Organometallic precursor compounds | PRAXAIR TECHNOLOGY, INC. (US) | 2013-03-19 | — | — | US | disclosed |
| US-20110293852-A1 | ORGANOMETALLIC PRECURSOR COMPOUNDS | PRAXAIR TECHNOLOGY, INC. | 2011-12-01 | — | — | US | disclosed |
| US-7332618-B2 | Organometallic precursor compounds | PRAXAIR TECHNOLOGY, INC. (US) | 2008-02-19 | — | — | US | disclosed |
| EP-1805195-A2 | ORGANOMETALLIC PRECURSOR COMPOUNDS | PRAXAIR TECHNOLOGY, INC. (US) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006036538-A2 | ORGANOMETALLIC PRECURSOR COMPOUNDS | PRAXAIR TECHNOLOGY, INC. (US) | 2006-04-06 | — | — | WO | disclosed |
| US-20060068102-A1 | Organometallic precursor compounds | PRAXAIR TECHNOLOGY, INC. | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110293852-A1 | ORGANOMETALLIC PRECURSOR COMPOUNDS | MSMO1, NNMT, DNMT1 | ALDH1A1 2176/4885SMN1; SMN2 1456/4885NISCH 1307/4885 |
| US-20060068102-A1 | Organometallic precursor compounds | MSMO1, NNMT, DNMT1 | ALDH1A1 2176/4885SMN1; SMN2 1456/4885NISCH 1307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.